Monitoring and assessing effectiveness of antiresorptive therapy in patients treated for osteopenia, osteoporosis, Paget's disease, or other disorders in which osteocalcin levels are elevated and as an adjunct in the diagnosis of medical conditions associated with increased bone turnover, including Paget's disease, cancer accompanied by bone metastases, primary hyperparathyroidism, and renal osteodystrophy.
Males <5 years: 19-75 ng/mL; 5-9 years: 21-108 ng/mL; 10-15 years: 19-159 ng/mL; 16-17: 12-114 ng/mL; > or =18 years: 9-42 ng/mL
Females <5 years: 14-126 ng/mL; 5-9 years: 16-152 ng/mL; 10-15 years: 15-151 ng/mL; 16-17 years: 9-70 ng/mL; > or =18 years: 9-42 ng/mL
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
2 - 5 days
- Osteocalcin, Human
Test sent to Mayo Medical Laboratories.